RNA-guided therapeutics
The company uses a cell-state-modifying platform to study the biology of long non-coding RNAs.
Source: LinkedIn company description · Retrieved October 13, 2026
HAYA Therapeutics develops RNA-guided programmable therapeutics targeting the regulatory genome for serious health conditions.
HAYA is headquartered in Lausanne, Switzerland, and has laboratory facilities in San Diego.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company uses a cell-state-modifying platform to study the biology of long non-coding RNAs.
Source: LinkedIn company description · Retrieved October 13, 2026
The pipeline includes candidates for diseases in the lungs and the microenvironment of solid tumor cancers.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 19, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.